{# ── Non-reliance notice. Reaching the live report with one of these means it did not meet the blocking bar (the 4.02 names this period outside the Item 4.02 body) or the viewer is staff. Either way the reader must not take the figures at face value. ── #}

Get notified when INGR files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NYSE: INGR Ingredion Inc 8-K

Tate & Lyle shareholders approve Ingredion's all-cash acquisition; close expected H2 2027

Filed July 28, 2026 · Period ending July 28, 2026 · ~1 min read

Key Changes

  • high

    Tate & Lyle shareholders voted to approve Ingredion's acquisition of the entire issued share capital through a court-sanctioned scheme of arrangement, satisfying a key closing condition for the transaction announced in June 2026.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • high

    The deal is expected to close in the second half of 2027, pending remaining conditions including material antitrust approvals and court sanction of the scheme.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →
  • medium

    Shareholders approved the scheme at a court-ordered meeting and passed necessary resolutions at a subsequent general meeting, following the UK scheme of arrangement process that requires both shareholder approval and court sanction.

    Item 7.01 — Regulation FD Disclosure verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.

Partner

Trade INGR commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify